FIGURE 2.

Losses and drop-outs at each stage of the latent tuberculosis cascade of care among all enrolled participants with a positive interferon-gamma release assay. IGRA, interferon-gamma release assay. Eligible participants for the first step, visiting clinics, were all participants with positive IGRA results. Eligible participants for the second step, initiating treatment, were participants with positive IGRA result, who did not have concurrent active TB. Eligible participants for the third step, completing treatment, were participants with positive IGRA result, who did not have concurrent active TB and who did not develop active TB during LTBI treatment.